DNA graphic

Search Results for: wallace

Dr. Daniel Wallace Appointed to Lupus Therapeutics Board

New York, NY, July 18, 2019 — The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel Wallace, MD joins as a new member of its Board of Directors.  Including lupus patients, family members and scientists, this governing body provides strategic insight and financial oversight to help the organization achieve its mission – […]

Welcoming Daniel J. Wallace, MD to Lupus Therapeutics

The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel J. Wallace, MD joins as a new member of its distinguished Board of Directors. A renowned leader in clinical research and care for lupus and other rheumatologic diseases, Dr. Wallace is Medical Director of the Wallace Rheumatic Study Center and Associate […]

Lupus Landmark Study

The Lupus Landmark Study (LLS) is a new, groundbreaking initiative designed to accelerate the development of personalized treatments for people living with lupus. Led by the Lupus Research Alliance and our clinical research affiliate Lupus Therapeutics, the LLS is the largest observational study of its kind in lupus. The LLS will follow and collect longitudinal […]

Lupus and COVID-19:What You Need to Know Webcast on Video

April 3, 2020 The Lupus Research Alliance (LRA) hosted a live webcast April 2, 2020 on COVID-19 for people with lupus that you won’t want to miss – so click here to view the full video recording. The webast addressed the most frequently asked questions doctors are hearing from people with lupus, put the hydroxychloroquine […]

DECLARACIÓN DEL 26 DE MARZO: La Alianza para la investigación de Lupus pone en perspectiva la escasez de Plaquenil (hidroxicloroquina) para la comunidad con lupus

26 de marzo de 2020 La Alianza para la investigación de Lupus (LRA), la principal organización de investigación del mundo dedicada a la investigación del lupus, continúa observando rápidamente los cambios en relación con la COVID-19 y está controlando de cerca las políticas y acciones del gobierno federal, las agencias de atención médica, las organizaciones […]

MARCH 26 STATEMENT: Lupus Research Alliance Puts Plaquenil (Hydroxychloroquine) Shortage into Perspective for Lupus Community

March 26, 2020 The Lupus Research Alliance (LRA), the world’s leading research organization dedicated to lupus research, continues to watch rapidly changing developments regarding COVID-19 and is closely monitoring the policies and actions of the federal government, healthcare agencies, medical organizations and the pharmaceutical industry on behalf of people with lupus. Thrust into the spotlight […]

New Study Shows Active Epstein-Barr Virus Increases Chance for Lupus in At-Risk People

August 13, 2019 New research results showed that active Epstein-Barr virus increases the risk for lupus among relatives of people who already have lupus. Epstein-Barr virus is one of the most common human viruses. After the first infection, the virus becomes inactive in your body and can reactivate at any time. Scientists have known that […]